Agilent Announces Unique Portfolio to Advance Immunotherapy
Agilent Technologies, Inc. (A)
Last agilent technologies, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.agilent.com
Company Research
Source: Business Wire
Innovative solution provides cell-based tools for translational research and development SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) announces a unified portfolio of products for immunotherapy researchers. The innovative solution will showcase at Immunology 2019, the 103rd Annual Meeting of the American Association of Immunologists (AAI), taking place in San Diego, CA on May 9-13, 2019. “Immunotherapy is changing the landscape of cancer treatment, but most of the available tools are adapted and not purpose-built for this cell-centric workflow,” said David Ferrick, Ph.D., senior director of the Cell Analysis Division at Agilent Technologies. “This is why we have placed so much emphasis on assembling and harmonizing innovative cell-based solutions. We want to enable researchers and developers to overcome the challenges and capture the opportunities of this r
Show less
Read more
Impact Snapshot
Event Time:
A
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
A alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
A alerts
High impacting Agilent Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
A
News
- Agilent to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Agilent Technologies, Inc. (NYSE: A) had its price target raised by analysts at Citigroup Inc. to $165.00. They now have a "buy" rating on the stock.MarketBeat
- Genomics in Cancer Care: North American Market Growth Forecasts and Business Opportunities, 2024-2031 [Yahoo! Finance]Yahoo! Finance
- Preimplantation Genetic Testing Market to hit USD 1.7 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- Agilent Technologies, Inc. (NYSE: A) had its price target lowered by analysts at Bank of America Co. from $153.00 to $150.00. They now have a "neutral" rating on the stock.MarketBeat
A
Earnings
- 11/25/24 - Beat
A
Sec Filings
- 12/20/24 - Form 10-K
- 12/13/24 - Form 8-K
- 12/3/24 - Form 4
- A's page on the SEC website